Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Patient Protection and Affordable Care Act (PPACA), Emerging Infections Program (EIP), Enhancing Epidemiology and Laboratory Capacity, Funding Opportunity Announcement CI10-003; Initial Review; Correction, 43993 [2010-18401]

Download as PDF Federal Register / Vol. 75, No. 143 / Tuesday, July 27, 2010 / Notices Development Status: In clinical trials. Market: An estimated three million individuals in the United States will have an advanced form of AMD by 2020 (Klein R et al. The epidemiology of agerelated macular degeneration. Am J Ophthalmol. 2004;137(3):486–95). Inventors: Robert B. Nussenblatt and Frederick L. Ferris (NEI). Publication: In preparation. Patent Status: U.S. Provisional Application No. 61/254,439 filed 23 Oct 2009 (HHS Reference No. E–198–2008/ 0–US–01). Licensing Status: Available for licensing. Licensing Contact: Norbert Pontzer, J.D., PhD; 301–435–5502; pontzern@mail.nih.gov. Collaborative Research Opportunity: The National Eye Institute, Laboratory of Immunology, is seeking statements of capability or interest from parties interested in collaborative research to further develop, evaluate, or commercialize the use of immunosuppressive agents in the treatment of age related macular degeneration. This is in light of new findings that immune mechanisms appear to be central to the expression of the clinical disease we know as AMD. Please contact Alan Hubbs, PhD at 301– 594–4263 or hubbsa@mail.nih.gov for more information. Dated: July 12, 2010. Richard U. Rodriguez, Director, Division of Technology Development and Transfer, Office of Technology Transfer, National Institutes of Health. [FR Doc. 2010–17446 Filed 7–26–10; 8:45 am] BILLING CODE 4140–01–M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention sroberts on DSKD5P82C1PROD with NOTICES Disease, Disability, and Injury Prevention and Control Special Emphasis Panel: Patient Protection and Affordable Care Act (PPACA), Emerging Infections Program (EIP), Enhancing Epidemiology and Laboratory Capacity, Funding Opportunity Announcement CI10–003; Initial Review; Correction Correction: This notice was published in the Federal Register on July 7, 2010, Volume 75, Number 129, page 39033. The time and date should read as follows: Time and Date: 8 a.m.–5 p.m., September 8, 2010 (Closed). CONTACT PERSON FOR MORE INFORMATION: Gregory Anderson, M.S., M.P.H., VerDate Mar<15>2010 16:30 Jul 26, 2010 Jkt 220001 Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, Atlanta, GA 30333, Telephone: (404) 498–2293. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 20, 2010. Michael J. Lanzilotta, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2010–18401 Filed 7–26–10; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Biomedical Imaging and Bioengineering; Notice of Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the National Advisory Council for Biomedical Imaging and Bioengineering. The meeting will be open to the public as indicated below, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and/or contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications and/or contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Advisory Council for Biomedical Imaging and Bioengineering, NACBIB September 2010. Date: September 13, 2010. Open: 9 a.m. to 1 p.m. Agenda: Report from the Institute Director, other Institute Staff and presentations of working group reports. PO 00000 Frm 00079 Fmt 4703 Sfmt 4703 43993 Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Closed: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications and/or proposals. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Independence Room (2nd Level), Bethesda, MD 20817. Contact Person: Anthony Demsey, PhD, Director, National Institute of Biomedical Imaging and Bioengineering, 6707 Democracy Boulevard, Room 241, Bethesda, MD 20892. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. Information is also available on the Institute’s/Center’s home page: https:// www.nibib1.nih.gov/about/NACBIB/ NACBIB.htm, where an agenda and any additional information for the meeting will be posted when available. Dated: July 21, 2010. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2010–18385 Filed 7–26–10; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Service Administration Advisory Committee on Interdisciplinary, Community-Based Linkages; Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), notice is hereby given of the following meeting: Name: Advisory Committee on Interdisciplinary, Community-Based Linkages (ACICBL). Dates and Times: August 19, 2010, 8:30 a.m. to 5 p.m., EST. August 20, 2010, 8:30 a.m. to 3 p.m., EST. Place: Hilton Washington DC/Rockville Hotel & Executive Meeting Ctr, 1750 Rockville Pike, Rockville, Maryland 20852. Status: The meeting will be open to the public. Purpose: The Committee members will advance their efforts in the development of the Tenth Annual Report to the Secretary of the Department of Health and Human Services (the Secretary) and the Congress, focusing on the topic, Preparing the Interprofessional Workforce to Manage Health Behaviors. The Committee proposes to review concepts behind the initiation of a new degree program in Health Care Delivery Science established at Dartmouth University as it relates to managing health behaviors and ensuring a workforce that is prepared to address health behaviors in its education and E:\FR\FM\27JYN1.SGM 27JYN1

Agencies

[Federal Register Volume 75, Number 143 (Tuesday, July 27, 2010)]
[Notices]
[Page 43993]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-18401]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel: Patient Protection and Affordable Care Act (PPACA), 
Emerging Infections Program (EIP), Enhancing Epidemiology and 
Laboratory Capacity, Funding Opportunity Announcement CI10-003; Initial 
Review; Correction

    Correction: This notice was published in the Federal Register on 
July 7, 2010, Volume 75, Number 129, page 39033. The time and date 
should read as follows:
    Time and Date: 8 a.m.-5 p.m., September 8, 2010 (Closed).

CONTACT PERSON FOR MORE INFORMATION: Gregory Anderson, M.S., M.P.H., 
Scientific Review Officer, CDC, 1600 Clifton Road, NE., Mailstop E60, 
Atlanta, GA 30333, Telephone: (404) 498-2293.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: July 20, 2010.
Michael J. Lanzilotta,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 2010-18401 Filed 7-26-10; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.